Clinical Trial:

TOTAL Pilot Trial

Full Name

Heart Attack(TOTAL): A randomized trial of routine aspiration ThrOmbecTomy with PCI versus PCI ALone in patients with STEMI undergoing primary PCI (1_PRO00000992)

Description

Approximately 7,000 patients will be enrolled on this study worldwide. Participation in the study will last approximately 1 year. Participants will be randomly assigned to percutaneous coronary intervention (PCI) alone or to aspiration thrombectomy (removal of the clot by suctioning it out through a tube) with PCI. Participants will need to complete a follow-up visit at 30 days, 180 days and one year, by telephone or office visit.

Eligibility

Inclusion Criteria
  • Must be greater than or equal to 18 years of age
  • Must not have had prior coronary artery bypass surgery (CABG)
  • Must present with symptoms of myocardial ischemia lasting for greater than or equal to 30 minutes
  • Must be randomized within 12 hours of symptom onset and prior to diagnostic angiography
Doctor(s) Running This Study

Specialties

  • Cardiology
  • Interventional Cardiology

Area of focus i

  • Interventional Cardiology
  • High Risk Coronary intervention
  • Transcatheter Aortic Valve Replacement (TAVR)

Affiliated with

LVPG Cliniciani

Accepting New Patients